Literature DB >> 10030309

Evaluating the appropriateness of digoxin level monitoring.

F Cañas1, M J Tanasijevic, N Ma'luf, D W Bates.   

Abstract

BACKGROUND: Digoxin level determinations can be useful clinically in patients receiving digoxin therapy but are sometimes misused.
METHODS: Explicit appropriateness criteria were adapted from previously published criteria and revised using local expert opinion. They were then used to evaluate the appropriateness of random samples of inpatient and outpatient serum digoxin levels. Overall agreement between reviewers regarding appropriateness was good (K = 0.65). Patients in the study included 162 inpatients in whom 224 digoxin levels were measured and 117 outpatients in whom 130 digoxin levels were measured during a 6-month period. The main outcome measure was the proportion of digoxin levels with an appropriate indication.
RESULTS: Among inpatient levels, only 16% (95% confidence intervals [CI], 11%-20%) were appropriate. Of the 189 digoxin levels considered inappropriate, only 26 (14%) had a result of 2.3 nmol/L or more (> or =1.8 ng/ mL). None of these levels resulted in an important change in therapy, and no patient had a toxic reaction to the therapy. Among inappropriate levels, daily routine monitoring accounted for 78%. Of the 130 outpatient levels, 52% (95% CI, 44%-61%) were appropriate. Of 62 inappropriate levels, only 4 (6%) had a result of 2.3 nmol/L or more (> or =1.8 ng/mL). One result led to a change in therapy, but none of the patients were believed to experience a toxic reaction. Among the inappropriate levels, 87% of patients underwent early routine monitoring before a steady state was achieved.
CONCLUSIONS: A high proportion of digoxin levels were inappropriate, particularly among inpatients. In both groups, the primary reason tests were judged inappropriate was early routine monitoring. Few inappropriate tests resulted in important data. Interventions to improve the use of digoxin levels could potentially save substantial resources without missing important clinical results.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030309     DOI: 10.1001/archinte.159.4.363

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  End of visit: design considerations for an ambulatory order entry module.

Authors:  Samuel J Wang; Barry H Blumenfeld; Susan E Roche; Julia A Greim; Karen E Burk; Tejal K Gandhi; David W Bates; Gilad J Kuperman
Journal:  Proc AMIA Symp       Date:  2002

2.  Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality.

Authors:  David W Bates; Gilad J Kuperman; Samuel Wang; Tejal Gandhi; Anne Kittler; Lynn Volk; Cynthia Spurr; Ramin Khorasani; Milenko Tanasijevic; Blackford Middleton
Journal:  J Am Med Inform Assoc       Date:  2003-08-04       Impact factor: 4.497

3.  David Westfall Bates, MD: a conversation with the editor on improving patient safety, quality of care, and outcomes by using information technology. Interview by William Clifford Roberts.

Authors:  David Westfall Bates
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

Review 4.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

5.  Appropriateness of serum digoxin levels.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Giorgio Brocco; Gian Cesare Guidi
Journal:  Eur J Clin Pharmacol       Date:  2007-09-16       Impact factor: 2.953

Review 6.  Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin.

Authors:  W Stuart A Smellie; Jamie J Coleman
Journal:  BMJ       Date:  2007-02-10

Review 7.  Medication-related clinical decision support in computerized provider order entry systems: a review.

Authors:  Gilad J Kuperman; Anne Bobb; Thomas H Payne; Anthony J Avery; Tejal K Gandhi; Gerard Burns; David C Classen; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2006-10-26       Impact factor: 4.497

8.  Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?

Authors:  Wesley D Kufel; Robert W Seabury; William Darko; Luke A Probst; Christopher D Miller
Journal:  Hosp Pharm       Date:  2017-03

9.  Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs.

Authors:  Manika Suryadevara; Kelly E Steidl; Luke A Probst; Jana Shaw
Journal:  J Pediatr Pharmacol Ther       Date:  2012-04

10.  Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study.

Authors:  Seyma Oncu; Anil Baskurt; Bihter Senturk; Ozgur Aslan; Tuncay Kume; Reyhan Ucku; Ayse Gelal
Journal:  Eur J Hosp Pharm       Date:  2019-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.